ReviewCurrent opinion in immunology2011
Advances in atopic dermatitis.
Review in Current opinion in immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 92 citations in OpenAlex.
- Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis.Experimental dermatology · 2017Trial
- Perfluorononanoic Acid (PFNA) Exacerbates Atopic Dermatitis by Inducing Inflammation in Mice.Toxics · 2025Article
- Indoor endotoxin and house dust mite concentrations in the canine homologue of human atopic dermatitis.One health (Amsterdam, Netherlands) · 2025Article
- Dermatologic presentations of hyper IgE syndrome in pediatric patients.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2025Review
- Nutritional Status and Severity of Atopic Dermatitis in Children in a Hospital Setting in Kinshasa, Democratic Republic of the Congo.Clinical, cosmetic and investigational dermatology · 2025Article
- Impact of atopic dermatitis on renal dysfunction: insights from patient data and animal models.Frontiers in immunology · 2025Article
- Article
- Early exposure to maternal stress and risk for atopic dermatitis in children: A systematic review and meta-analysis.Clinical and translational allergy · 2024Review
- Mānuka oil based ECMT-154 versus vehicle control for the topical treatment of eczema: study protocol for a randomised controlled trial in community pharmacies in Aotearoa New Zealand.BMC complementary medicine and therapies · 2024Article
- Anti-Inflammatory Herbal Extracts and Their Drug Discovery Perspective in Atopic Dermatitis.Biomolecules & therapeutics · 2024Review
- Evaluation of the effect of the interleukin-25 serum concentration on the intensity of the symptoms of atopic dermatitis and epidermal barrier.Postepy dermatologii i alergologii · 2021Article
- New Treatments for Atopic Dermatitis Targeting Skin Barrier Repair via the Regulation of FLG Expression.Journal of clinical medicine · 2021Review
- Cytokines and apoptosis in atopic dermatitis.Postepy dermatologii i alergologii · 2021Review
- Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis.International journal of molecular sciences · 2020Review
- The Beneficial Effect of Korean Red Ginseng Extract on Atopic Dermatitis Patients: An 8 Weeks Open, Noncomparative Clinical Study.Annals of dermatology · 2018Article
- Involvement of Fas/FasL pathway in the murine model of atopic dermatitis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017Article
- TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents.Scientific reports · 2017Article
- Clinical Diversity of Atopic Dermatitis: A Review of 5,000 Patients at a Single Institute.Allergy, asthma & immunology research · 2017Article
- Mechanism of Sleep Disturbance in Children with Atopic Dermatitis and the Role of the Circadian Rhythm and Melatonin.International journal of molecular sciences · 2016Review
- Phospholipid analysis in sera of horses with allergic dermatitis and in matched healthy controls.Lipids in health and disease · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
Abstract
Atopic dermatitis (AD) results from barrier defects combined with modified immune responses of the innate and the adaptive immune system to exogenous and endogenous factors. Recent research has continued to sort out the complex pathophysiologic puzzle of this frequent skin disease. However, the network of mechanisms leading to the manifestation of AD is far from being completely understood.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.